Mizuho Securities USA’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Mizuho Securities USA’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-203,400	Closed	-$832K	–	242
2018 Q1	$832K	Buy	203,400 +50,000	+33%	+$233K	0.05%	84
2017 Q4	$713K	Buy	+153,400	New	+$845K	0.04%	118
2016 Q3	–	Sell	-31,700	Closed	-$210K	–	248
2016 Q2	$210K	Hold	31,700	–	–	0.03%	157
2016 Q1	$148K	Sell	31,700 -276,200	-90%	-$1.1M	0.03%	101
2015 Q4	$1.55M	Buy	307,900 +54,100	+21%	+$257K	0.19%	65
2015 Q3	$893K	Buy	253,800 +72,100	+40%	+$483K	0.23%	55
2015 Q2	$1.81M	Buy	181,700 +176,700	+3,534%	+$1.89M	0.22%	52
2015 Q1	$64K	Buy	+5,000	New	+$64.3K	0.01%	225

Other funds holding KERX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PIMJS

PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mizuho Securities USA's KERX Position: Q2 2018 in Review

Mizuho Securities USA sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2018, closing a stake of 203,400 shares — an estimated $832K sold.

Mizuho Securities USA first reported a position in KERX in Q1 2015 and held it in 8 quarters. The position peaked at $1.81M in Q2 2015. 132 funds tracked by Wall St. Rank hold KERX as of Q2 2018.

Mizuho Securities USA reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2018 after selling out during the quarter.
Mizuho Securities USA sold 203,400 Keryx Biopharmaceuticals Inc shares in Q2 2018, an estimated $832K.
Mizuho Securities USA first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 8 quarters.
Mizuho Securities USA's Keryx Biopharmaceuticals Inc position peaked at $1.81M in Q2 2015.
132 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2018.

Based on Mizuho Securities USA's 13F filing for Q2 2018, filed 23 Jul 2018.